140 related articles for article (PubMed ID: 35970488)
1. An overview of red blood cell and platelet alloimmunisation in transfusion.
Garraud O; Chiaroni J
Transfus Clin Biol; 2022 Nov; 29(4):297-306. PubMed ID: 35970488
[TBL] [Abstract][Full Text] [Related]
2. Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.
Moncharmont P; Barday G; Py JY; Meyer F;
Blood Transfus; 2017 May; 15(3):254-258. PubMed ID: 27416567
[TBL] [Abstract][Full Text] [Related]
3. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
Moncharmont P
Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
[TBL] [Abstract][Full Text] [Related]
5. Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion.
Garraud O; Cognasse F; Moncharmont P
Diseases; 2019 Jan; 7(1):. PubMed ID: 30646515
[TBL] [Abstract][Full Text] [Related]
6. The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation.
Oud JA; Evers D; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; Albersen A; van der Bom JG; Zwaginga JJ
Br J Haematol; 2021 Nov; 195(4):604-611. PubMed ID: 34346067
[TBL] [Abstract][Full Text] [Related]
7. Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service.
Pereira Bueno ML; Mitestainer MB; Da Silva JAR; Benites BD; Roversi FM
Transfus Clin Biol; 2021 Aug; 28(3):258-263. PubMed ID: 33901640
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
[TBL] [Abstract][Full Text] [Related]
10. Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.
Madrid DJ; Santhanakrishnan M; Liu J; Gibb DR; Liu D; Natarajan P; Beitler D; Shi Z; Mo C; Tormey CA; Patel SR; Stowell SR; Hendrickson JE
Blood Transfus; 2019 Sep; 17(5):368-377. PubMed ID: 30418129
[TBL] [Abstract][Full Text] [Related]
11. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
Regalado-Artamendi I; Pérez-Corral AM; García-Morín M; Cela E; Beléndez C; Bardón-Cancho EJ; Pérez-Rus G; Pérez-Sánchez I; Pascual C; Monsalvo S; Falero C; Díez-Martín JL; Anguita J
Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
[TBL] [Abstract][Full Text] [Related]
12. [Transfusion and alloimmunization in sickle cell anemia patients].
Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
[TBL] [Abstract][Full Text] [Related]
13. Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
Saris A; Peyron I; van der Meer PF; Stuge TB; Zwaginga JJ; van Ham SM; Ten Brinke A
Front Immunol; 2018; 9():1251. PubMed ID: 29951051
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
15. Platelet transfusions: the problem of refractoriness.
Murphy MF; Waters AH
Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145
[TBL] [Abstract][Full Text] [Related]
16. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
Rodrigues C; Sell AM; Guelsin GAS; Higa TT; Pagliarini E Silva S; Macedo LC; Sippert EÂ; de Alencar JB; Zanette Â; Acorsi CRL; Castilho L; Visentainer JEL
Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
[TBL] [Abstract][Full Text] [Related]
17. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
Amemiya Y
Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
[TBL] [Abstract][Full Text] [Related]
18. Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India.
Pujani M; Pahuja S; Dhingra B; Chandra J; Jain M
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s100-4. PubMed ID: 23399366
[TBL] [Abstract][Full Text] [Related]
19. Prevention and management of platelet transfusion refractoriness.
Novotny VM
Vox Sang; 1999; 76(1):1-13. PubMed ID: 9933848
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.
Martins JO; Moritz E; Abbas SA; Lopes LB; Barros MMO; Chiba AK; Langhi DM; Bordin JO
Blood Transfus; 2021 Nov; 19(6):479-486. PubMed ID: 33085600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
